ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,468Medicare Part D Prescriptions Filled, Including Refills

Rank: 81 out of 1844

$870K Total Retail Price of All Prescriptions

Rank: 81 out of 1844

366 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 366 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

25% of this provider’s 366 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 10,915 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 531 456 S3 1 2
POTASSIUM CHLORIDE 505 421 2 16
OMEPRAZOLE 484 356 3 5
FUROSEMIDE 461 402 4 7
WARFARIN SODIUM 401 393 5 13
PRAVASTATIN SODIUM 318 219 6 10
LEVOTHYROXINE SODIUM 309 276 7 1
ZOLPIDEM TARTRATE 303 194 8 23
GABAPENTIN 288 202 9 15
LISINOPRIL 259 179 10 4
POLYETHYLENE GLYCOL 3350 217 165 11 39
AMLODIPINE BESYLATE 214 180 12 6
METFORMIN HCL 183 72 13 8
HYDRALAZINE HCL 165 154 14 120
MIRTAZAPINE 164 145 15 49
DONEPEZIL HCL 161 159 16 26
ISOSORBIDE MONONITRATE ER 156 141 17 59
LISINOPRIL-HYDROCHLOROTHIAZIDE 150 112 18 20
HYDROCHLOROTHIAZIDE 145 87 19 9
TAMSULOSIN HCL 139 117 20 27
ALLOPURINOL 138 124 21 29
METOPROLOL TARTRATE 137 106 22 11
NAMENDA 134 134 23 33
CARVEDILOL 131 131 24 22
TRAMADOL HCL 131 60 24 18
IPRATROPIUM-ALBUTEROL 130 130 26 113
SIMVASTATIN 128 107 27 3
SPIRIVA 128 103 27 57
RANITIDINE HCL 127 96 29 38
ROPINIROLE HCL 123 101 30 76
SERTRALINE HCL 122 118 31 21
CEPHALEXIN 118 103 32 56
DIGOXIN 118 100 32 67
RISPERIDONE 117 109 34 65
SINGULAIR 113 80 35 102
METOCLOPRAMIDE HCL 112 72 36 148
TRAZODONE HCL 112 64 36 43
OLANZAPINE 108 82 38 117
PROAIR HFA 107 35 39 45
LOSARTAN POTASSIUM 104 71 40 24
PAROXETINE HCL 104 92 40 68
ATENOLOL 99 62 42 17
ENALAPRIL MALEATE 95 80 43 69
CYMBALTA 94 48 44 36
NOVOLOG FLEXPEN 85 56 45 163
PREDNISONE 84 67 46 40
CITALOPRAM HBR 83 73 47 19
SULFAMETHOXAZOLE-TRIMETHOPRIM 80 57 48 73
PROMETHAZINE HCL 80 50 R 48 88
CIPROFLOXACIN HCL 79 64 50 62
CRESTOR 79 66 50 30
LYRICA 75 42 52 92
ADVAIR DISKUS 75 47 52 51
NASONEX 75 53 52 273
BUMETANIDE 72 68 55 121
HYDROXYZINE HCL 72 28 R 55 164
ALBUTEROL SULFATE 69 69 57 115
AZITHROMYCIN 68 47 58 37
ZETIA 67 16 59 81
SPIRONOLACTONE 67 67 59 60
GLIPIZIDE 65 35 61 70
LEVEMIR FLEXPEN 65 40 61 166
DIVALPROEX SODIUM 65 43 61 74
ESCITALOPRAM OXALATE 63 57 64 52
TIZANIDINE HCL 62 49 65 141
AVELOX 62 55 65 346
MECLIZINE HCL 62 43 65 142
QUETIAPINE FUMARATE 61 33 68 82
OXYCODONE HCL 60 31 S2 69 104
MONTELUKAST SODIUM 58 41 70 195
METOPROLOL SUCCINATE 56 35 71 14
PHENYTOIN SODIUM EXTENDED 56 35 71 147
VENTOLIN HFA 56 39 71 145
ATORVASTATIN CALCIUM 54 32 74 12
FLUTICASONE PROPIONATE 53 40 75 50
CLOPIDOGREL 52 43 76 34
CARBIDOPA-LEVODOPA 51 42 77 86
GLIMEPIRIDE 51 25 77 35
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 27, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.